Menopause & HRT:
The FDA Roundtable That’s Changing the Conversation

Hey ladies (and the wonderful men who love us!), ever felt like menopause was a medical mystery shrouded in fear and outdated advice? Well, get ready for a breath of fresh air, because something big just happened at the FDA. Recently, top experts, including the Director of the FDA, gathered for a no-holds-barred discussion on menopause and perimenopause, aiming to sweep away old research and shine a bright, scientific light on what we really know today. And trust me, for any woman who’s been hesitant about Hormone Replacement Therapy (HRT), this is going to be profoundly impactful.

The Ghost of 2002: Busting the Myths of the WHI Study

For years, the Women’s Health Initiative (WHI) study from 2002 loomed large, scaring millions of women (and their doctors!) away from HRT. The headlines screamed “breast cancer” and “heart attack,” and as Dr. Makary put it, “women flushed their pills down the toilet.” But what this groundbreaking FDA roundtable revealed is that history got it wrong.

  • Age Matters: A major takeaway is that the average age of women in the original WHI study was 63—much older than when most women typically start experiencing menopausal symptoms. Re-analysis of the data (like the 2017 study by Dr. Manson) showed that for women under 60 or within 10 years of menopause onset, there was actually a decrease in all-cause mortality among those taking HRT. Phew!
  • Not All Hormones Are Created Equal: As Dr. Barbara Levy passionately explained, “Not all hormones are the same.” The WHI largely studied a specific type of conjugated estrogen and progestin, which isn’t chemically identical to the natural, human-identical estradiol and micronized progesterone often used today. The route of administration (oral, transdermal, vaginal) also makes a huge difference in how hormones affect the body.
  • Breast Cancer Nuance: This was a big one. While initial alarms were raised, the experts clarified that the 2002 WHI paper showed no statistically significant increase in breast cancer mortality. In fact, for estrogen-alone therapy, there was a decrease in breast cancer incidence. The notion that HRT is a “carcinogen” was, as Dr. Hodis meticulously detailed, largely a misinterpretation and fear-mongering.

Vaginal Estrogen: A Clear Case for Safety

Perhaps one of the most frustrating myths debunked was around local vaginal estrogen. This medication, used for incredibly common and often debilitating issues like dryness, painful sex (Genitourinary Syndrome of Menopause or GSM), and recurrent UTIs, carries an alarming “black box warning” – the highest safety warning the FDA can place on a medication.

  • It Stays Local: The panel, including Dr. Heather Hirsch and Dr. JoAnn Pinkerton, emphatically stated that local vaginal estrogen does not travel systemically through the body. This means it doesn’t increase the risks of heart attacks, strokes, or systemic cancers. As Dr. James Simon put it, “You cannot measure them in the blood.”
  • Why the Warning? The black box warning on vaginal estrogen is largely a relic, extrapolated from systemic hormone therapy trials in older women. It’s causing unnecessary fear, with Dr. Pinkerton sharing a heartbreaking anecdote of a patient whose partner threw her estrogen cream in the trash out of fear. Dr. Rachel Rubin even shared a personal, critical story of how this unwarranted fear nearly cost her mother her life in the ICU due to a preventable UTI. The consensus? This warning is wrong and needs to be removed immediately.

Beyond Hot Flashes: The Unsung Benefits of Estrogen

While alleviating hot flashes and night sweats is a common reason women seek HRT, the roundtable highlighted a myriad of other profound, long-term health benefits that have been overshadowed by past misinformation.

  • Heart Health: Estrogen has a powerful cardio-protective effect. Studies show that when initiated within 10 years of menopause (or before age 60), HRT can lead to a 25-50% reduction in fatal heart attacks and cardiovascular disease—a risk reduction comparable to or even greater than statins!
  • Bone Strength: Osteoporosis is a silent thief, leading to debilitating fractures, especially hip fractures, which have a shockingly high one-year mortality rate (22% for women over 80). HRT, when started timely, can reduce the risk of broken fractures by up to 50%, a point passionately driven home by orthopedic surgeon Dr. Vonda Wright, who is “tired of having to put big metal objects” in women’s bodies for a preventable condition.

Brain Power: Dr. Roberta Diaz Brinton revealed estrogen as a “master regulator” in the brain. Estrogen depletion can lead to cognitive disturbance, mood swings, and sleep issues. Studies even suggest HRT is associated with a reduced risk of Alzheimer’s and other neurodegenerative diseases, particularly when started early. Dr. Philip Sarrel shared powerful examples of women whose work abilities and daily lives were profoundly impacted by menopausal brain fog, only to be restored with estrogen therapy.

Empowering Yourself: Navigating Menopause Care

The experts acknowledged that finding appropriate menopause care can be challenging, often involving a “time-consuming diagnosis process” and a risk of symptoms being dismissed. However, they offered clear guidance for women seeking support:

  • Identify Knowledgeable Practitioners: As Dr. Pinkerton advised, seek a menopause-credentialed practitioner. The North American Menopause Society website, menopause.org, offers a “Find a practitioner” tool. For those in the Las Vegas Valley, Xena Health in Henderson, NV, is a leading Menopause and Perimenopause Focused clinic, owned by Cherie Little, a National Menopause Society Certified Practitioner.
  • Inquire Before Your Visit: To save time and ensure the clinic meets your needs, call ahead and ask: “Do you specialize in menopause care, and do your practitioners prescribe hormones if appropriate?”
  • Engage as a Partner in Your Care: Once in the clinic, empower yourself by initiating the conversation. Consider saying: “I’ve learned about new data on hormones. Would it be possible to explore options like [vaginal estrogen, a low-dose patch, etc.]? I’m committed to follow-up in three months so we can adjust the dosage as needed.” This proactive approach fosters collaboration with your doctor.

A New Era for Women's Health

This FDA roundtable wasn’t just a discussion; it was a powerful call to action. It’s time to move beyond the fear and embrace the evidence. As the FDA Deputy Assistant Secretary of Health, Dr. Dorothy Fink, beautifully summarized, “What an incredible group of people here today to really be thinking like if you have a symptom and you’re not getting answers, there’s so much hope out there and keep trying to connect those dots and help to connect those dots for friends and family and we really look forward to continuing to engage with all of you, and taking next steps to really change women’s lives.”

The conversation is far from over, but one thing is clear: the future of menopause care is looking a whole lot brighter and more evidence-based. It’s about time, don’t you think?

The full youtube video can be found here.

More Posts

a man and woman lying on a bed trt hrt

The Power of Balance

The Power of Balance: TRT & HRT How Testosterone Replacement Therapy (TRT) and Hormone Replacement Therapy (HRT) Can Transform Couples’ Lives Let’s be honest: life

a woman lifting weights in a gym

Testosterone For Women

Testosterone The Hormone You Didn’t Know You Needed   Let’s Talk About Testosterone: The Hormone You Didn’t Know You Needed When we hear the word

Send Us A Message